Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-10-30 4:00 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 1,964,268 9.78% | 1,964,268 (New Position) | View |
2020-10-16 4:00 pm Purchase | 13G | C4 THERAPEUTICS INC CCCC | Cormorant Asset Management LP | 2,490,068 5.79% | 2,490,068 (New Position) | View |
2020-07-20 4:03 pm Purchase | 13G | OTONOMY INC OTIC | Cormorant Asset Management LP | 2,500,000 5.2% | 2,500,000 (New Position) | View |
2020-07-06 4:01 pm Purchase | 13G | FORMA THERAPEUTICS HLDGS INC FMTX | Cormorant Asset Management LP | 3,379,370 8.76% | 3,379,370 (New Position) | View |
2020-06-29 5:22 pm Unchanged | 13G | AVEO PHARMACEUTICALS INC AVEO | Cormorant Asset Management LP | 1,350,000 5.23% | 0 (Unchanged) | View |
2020-06-29 5:22 pm Purchase | 13G | AVEO PHARMACEUTICALS INC AVEO | Cormorant Asset Management LP | 1,350,000 5.23% | 1,350,000 (New Position) | View |
2020-06-26 4:17 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | Cormorant Asset Management LP | 2,514,545 6.7% | 2,514,545 (New Position) | View |
2020-05-04 4:15 pm Purchase | 13G | OMEROS CORPORATION OMER | Cormorant Asset Management LP | 3,100,000 5.5% | 2,200,000 (+244.44%) | View |
2020-04-27 4:05 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Cormorant Asset Management LP | 1,144,537 5.76% | 1,144,537 (New Position) | View |
2020-03-20 4:00 pm Purchase | 13G | AGENUS INC AGEN | Cormorant Asset Management LP | 11,500,000 7.12% | 11,500,000 (New Position) | View |
2020-02-24 4:01 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Cormorant Asset Management LP | 3,245,177 5.5% | 3,245,177 (New Position) | View |
2020-02-14 4:07 pm Sale | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Cormorant Asset Management LP | 2,700,000 3.61% | -1,802,498 (-40.03%) | View |
2020-02-14 4:07 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | Cormorant Asset Management LP | 488,565 2.99% | -451,822 (-48.05%) | View |
2020-02-14 4:06 pm Purchase | 13G | TURNING PT THERAPEUTICS INC CO TPTX | Cormorant Asset Management LP | 3,396,650 9.47% | 274,283 (+8.78%) | View |
2020-02-14 4:06 pm Sale | 13G | STOKE THERAPEUTICS INC STOK | Cormorant Asset Management LP | 1,788,663 5.46% | -81,017 (-4.33%) | View |
2020-02-14 4:06 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | Cormorant Asset Management LP | 0 0% | -3,481,471 (Position Closed) | View |
2020-02-14 4:05 pm Purchase | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management LP | 2,119,133 8.82% | 1 (+0.00%) | View |
2020-02-14 4:05 pm Sale | 13G | NEXTCURE INC NXTC | Cormorant Asset Management LP | 1,000,000 3.65% | -428,577 (-30.00%) | View |
2020-02-14 4:05 pm Purchase | 13G | IMMUNOVANT INC IMVT | Cormorant Asset Management LP | 1,080,000 1.91% | 1,080,000 (New Position) | View |
2020-02-14 4:04 pm Sale | 13G | QUOTIENT LIMITED QTNT | Cormorant Asset Management LP | 3,500,000 4.36% | -1,262,772 (-26.51%) | View |